Hybrigenics Société Anonyme
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, Fr… Read more
Hybrigenics Société Anonyme (3HB) - Total Assets
Latest total assets as of June 2025: €5.62 Million EUR
Based on the latest financial reports, Hybrigenics Société Anonyme (3HB) holds total assets worth €5.62 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hybrigenics Société Anonyme - Total Assets Trend (2016–2024)
This chart illustrates how Hybrigenics Société Anonyme’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hybrigenics Société Anonyme - Asset Composition Analysis
Current Asset Composition (December 2024)
Hybrigenics Société Anonyme's total assets of €5.62 Million consist of 20.9% current assets and 79.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.3% |
| Accounts Receivable | €182.00K | 2.8% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.38 Million | 21.4% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Hybrigenics Société Anonyme's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hybrigenics Société Anonyme's current assets represent 20.9% of total assets in 2024, a decrease from 93.0% in 2016.
- Cash Position: Cash and equivalents constituted 1.3% of total assets in 2024, down from 52.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 3.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 21.4% of total assets.
Hybrigenics Société Anonyme Competitors by Total Assets
Key competitors of Hybrigenics Société Anonyme based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Hybrigenics Société Anonyme - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hybrigenics Société Anonyme generates 0.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Hybrigenics Société Anonyme is currently not profitable relative to its asset base.
Hybrigenics Société Anonyme - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.33 | 0.24 | 4.56 |
| Quick Ratio | 0.33 | 0.24 | 4.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.69 Million | € -4.96 Million | € 2.69 Million |
Hybrigenics Société Anonyme - Advanced Valuation Insights
This section examines the relationship between Hybrigenics Société Anonyme's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.80 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -33.9% |
| Total Assets | €6.45 Million |
| Market Capitalization | $329.27K USD |
Valuation Analysis
Below Book Valuation: The market values Hybrigenics Société Anonyme's assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Hybrigenics Société Anonyme's assets decreased by 33.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Hybrigenics Société Anonyme (2016–2024)
The table below shows the annual total assets of Hybrigenics Société Anonyme from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €6.45 Million | -33.91% |
| 2023-12-31 | €9.76 Million | -35.79% |
| 2022-12-31 | €15.20 Million | +15.59% |
| 2021-12-31 | €13.15 Million | +104.80% |
| 2020-12-31 | €6.42 Million | +8.62% |
| 2019-12-31 | €5.91 Million | +47.98% |
| 2018-12-31 | €3.99 Million | -71.41% |
| 2017-12-31 | €13.97 Million | -13.65% |
| 2016-12-31 | €16.18 Million | -- |